Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

CollPlant Biotechnologies (CLGN) Gross Margin (2017 - 2025)

Historic Gross Margin for CollPlant Biotechnologies (CLGN) over the last 9 years, with Q3 2025 value amounting to 249.35%.

  • CollPlant Biotechnologies' Gross Margin rose 64506500.0% to 249.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 282764.97%, marking a year-over-year decrease of 2825378900.0%. This contributed to the annual value of 215.53% for FY2024, which is 2973700.0% down from last year.
  • Latest data reveals that CollPlant Biotechnologies reported Gross Margin of 249.35% as of Q3 2025, which was up 64506500.0% from 3910614.53% recorded in Q2 2025.
  • CollPlant Biotechnologies' 5-year Gross Margin high stood at 93.96% for Q2 2023, and its period low was 3910614.53% during Q2 2025.
  • Over the past 5 years, CollPlant Biotechnologies' median Gross Margin value was 71.31% (recorded in 2024), while the average stood at 297043.36%.
  • Its Gross Margin has fluctuated over the past 5 years, first surged by 2000000000bps in 2022, then crashed by 2000000000bps in 2025.
  • Quarter analysis of 5 years shows CollPlant Biotechnologies' Gross Margin stood at 76.77% in 2021, then surged by 91bps to 6.9% in 2022, then tumbled by -2199bps to 158.53% in 2023, then soared by 58bps to 65.85% in 2024, then plummeted by -279bps to 249.35% in 2025.
  • Its Gross Margin stands at 249.35% for Q3 2025, versus 3910614.53% for Q2 2025 and 90.85% for Q1 2025.